Porphyrias

Porphyrias are a group of rare metabolic disorders that arise from problems in the production of heme, a critical component of hemoglobin in blood, myoglobin in muscle tissue, and certain enzymes. The condition is characterized by an accumulation of porphyrins or porphyrin precursors, substances that are essential for the function of hemoglobin but become toxic when they build up. Porphyrias are generally inherited and can be classified into acute and cutaneous types, based on the symptoms they cause.

Classification

Porphyrias are classified into two major categories based on the primary site of overproduction and accumulation of porphyrins or their precursors: hepatic and erythropoietic.

• Hepatic porphyrias affect the liver and lead to symptoms related to the nervous system and the gastrointestinal tract. These include:
  • Acute Intermittent Porphyria (AIP)
  • Variegate Porphyria (VP)
  • Hereditary Coproporphyria (HCP)
  • Porphyria Cutanea Tarda (PCT)

• Erythropoietic porphyrias affect the bone marrow and skin. These include:
  • Congenital Erythropoietic Porphyria (CEP)
  • Erythropoietic Protoporphyria (EPP)

Symptoms

Symptoms of porphyrias vary widely among the different types but can be broadly categorized into those affecting the skin and those that are neurological.

• Cutaneous symptoms include sensitivity to sunlight, blisters, itching, and swelling on exposure to the sun.
• Neurological symptoms can range from mild, such as anxiety and insomnia, to severe, including pain, high blood pressure, and even paralysis.

Causes

Porphyrias are primarily caused by genetic mutations that lead to deficiencies in specific enzymes involved in the heme biosynthesis pathway. This deficiency results in the accumulation of porphyrins or their precursors, causing the symptoms of the disease.

Diagnosis

Diagnosis of porphyrias involves a combination of clinical evaluation, biochemical tests for porphyrins in blood, urine, and feces, and genetic testing to identify specific enzyme deficiencies or mutations.

Treatment

Treatment of porphyrias depends on the type and severity of the symptoms. It may include avoidance of sunlight, withdrawal of drugs that may exacerbate the condition, and in severe cases, blood transfusions or liver transplantation. Drugs that may be used include beta-carotene for skin protection and hemin for acute attacks.

Prognosis

The prognosis for individuals with porphyria varies depending on the type and severity of the disorder. With proper management, most individuals with porphyria can lead normal lives.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian